Wakimoto H - Search Results

1

Development of a novel non-human primate model for preclinical gene vector safety studies. Determining the effects of intracerebral HSV-1 inoculation in the common marmoset: a comparative study.

Deisboeck TS, Wakimoto H, Nestler U, Louis DN, Sehgal PK, Simon M, Chiocca EA, Hochberg FH. Deisboeck TS, et al. Among authors: wakimoto h. Gene Ther. 2003 Aug;10(15):1225-33. doi: 10.1038/sj.gt.3302003. Gene Ther. 2003. PMID: 12858187

2

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses.

Ikeda K, Ichikawa T, Wakimoto H, Silver JS, Deisboeck TS, Finkelstein D, Harsh GR 4th, Louis DN, Bartus RT, Hochberg FH, Chiocca EA. Ikeda K, et al. Among authors: wakimoto h. Nat Med. 1999 Aug;5(8):881-7. doi: 10.1038/11320. Nat Med. 1999. PMID: 10426310

3

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.

Ikeda K, Wakimoto H, Ichikawa T, Jhung S, Hochberg FH, Louis DN, Chiocca EA. Ikeda K, et al. Among authors: wakimoto h. J Virol. 2000 May;74(10):4765-75. doi: 10.1128/jvi.74.10.4765-4775.2000. J Virol. 2000. PMID: 10775615 Free PMC article.

4

The complement response against an oncolytic virus is species-specific in its activation pathways.

Wakimoto H, Ikeda K, Abe T, Ichikawa T, Hochberg FH, Ezekowitz RA, Pasternack MS, Chiocca EA. Wakimoto H, et al. Mol Ther. 2002 Mar;5(3):275-82. doi: 10.1006/mthe.2002.0547. Mol Ther. 2002. PMID: 11863417 Free article.

5

Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors.

Abe T, Wakimoto H, Bookstein R, Maneval DC, Chiocca EA, Basilion JP. Abe T, et al. Among authors: wakimoto h. Cancer Gene Ther. 2002 Mar;9(3):228-35. doi: 10.1038/sj.cgt.7700437. Cancer Gene Ther. 2002. PMID: 11896438

6

PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli.

Abe T, Terada K, Wakimoto H, Inoue R, Tyminski E, Bookstein R, Basilion JP, Chiocca EA. Abe T, et al. Among authors: wakimoto h. Cancer Res. 2003 May 1;63(9):2300-5. Cancer Res. 2003. PMID: 12727853

7

Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells.

Wakimoto H, Johnson PR, Knipe DM, Chiocca EA. Wakimoto H, et al. Gene Ther. 2003 Jun;10(11):983-90. doi: 10.1038/sj.gt.3302038. Gene Ther. 2003. PMID: 12756419 Review.

8

Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis.

Wakimoto H, Fulci G, Tyminski E, Chiocca EA. Wakimoto H, et al. Gene Ther. 2004 Jan;11(2):214-23. doi: 10.1038/sj.gt.3302143. Gene Ther. 2004. PMID: 14712306 Free PMC article.

9

The combination of adenoviral HSV TK gene therapy and radiation is effective in athymic mouse glioblastoma xenografts without increasing toxic side effects.

Nestler U, Wakimoto H, Siller-Lopez F, Aguilar LK, Chakravarti A, Muzikansky A, Stemmer-Rachamimov A, Chiocca EA, Aguilar-Cordova E, Hochberg FH. Nestler U, et al. Among authors: wakimoto h. J Neurooncol. 2004 Mar-Apr;67(1-2):177-88. doi: 10.1023/b:neon.0000021897.53969.ca. J Neurooncol. 2004. PMID: 15072465

10

Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.

Terada K, Wakimoto H, Tyminski E, Chiocca EA, Saeki Y. Terada K, et al. Among authors: wakimoto h. Gene Ther. 2006 Apr;13(8):705-14. doi: 10.1038/sj.gt.3302717. Gene Ther. 2006. PMID: 16421599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters